Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernest Nadal

Showing results (21-30 of 166) with videos related to

Pageof 17
Sort By:
Cellular Oncology (Dordrecht, Netherlands)|January 15, 2015
Intrinsic cancer subtypes--next steps into personalized medicineCristina Santos, Rebeca Sanz-Pamplona, Ernest Nadal, et al.
Cancers|October 13, 2021
Gene Expression Profiling as a Potential Tool for Precision Oncology in Non-Small Cell Lung CancerSara Hijazo-Pechero, Ania Alay, Raúl Marín, et al.
JTO Clinical and Research Reports|February 2, 2024
RELAY, Erlotinib Plus Ramucirumab in Untreated, <i>EGFR</i>-Mutated, Metastatic NSCLC: Outcomes by <i>EGFR</i> Exon 19 Deletion VariantsKazumi Nishino, Jin-Yuan Shih, Kazuhiko Nakagawa, et al.
Critical Reviews in Oncology/Hematology|May 17, 2019
Multidisciplinary expert opinion on the treatment consensus for patients with EGFR mutated NSCLC with brain metastasesSantiago Ponce, Jordi Bruna, Oscar Juan, et al.
JAMA Neurology|March 15, 2021
Encephalitis Induced by Immune Checkpoint Inhibitors: A Systematic ReviewRoser Velasco, Macarena Villagrán, Maria Jové, et al.
International Journal of Molecular Sciences|February 13, 2026
Urinary Chemokines in the Diagnosis and Monitoring of Immune Checkpoint Inhibitor-Associated NephritisFrancisco Gomez-Preciado, Laura Martinez-Valenzuela, Paula Anton-Pampols, et al.
BMC Pulmonary Medicine|March 3, 2021
Prognostic value of the preoperative lymphocyte-to-monocyte ratio for survival after lung cancer surgeryRicard Ramos, Ivan Macía, Arturo Navarro-Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2014
A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinomaErnest Nadal, Jinjie Zhong, Jules Lin, et al.
Molecular Oncology|November 9, 2023
Transcriptional analysis of landmark molecular pathways in lung adenocarcinoma results in a clinically relevant classification with potential therapeutic implicationsSara Hijazo-Pechero, Ania Alay, David Cordero, et al.
Scientific Reports|July 24, 2015
A Novel Serum 4-microRNA Signature for Lung Cancer DetectionErnest Nadal, Anna Truini, Asuka Nakata, et al.
Pageof 17

Showing results (21-30 of 166) with videos related to

Sort By:
Pageof 17
Cellular Oncology (Dordrecht, Netherlands)|January 15, 2015
Intrinsic cancer subtypes--next steps into personalized medicineCristina Santos, Rebeca Sanz-Pamplona, Ernest Nadal, et al.
Cancers|October 13, 2021
Gene Expression Profiling as a Potential Tool for Precision Oncology in Non-Small Cell Lung CancerSara Hijazo-Pechero, Ania Alay, Raúl Marín, et al.
JTO Clinical and Research Reports|February 2, 2024
RELAY, Erlotinib Plus Ramucirumab in Untreated, <i>EGFR</i>-Mutated, Metastatic NSCLC: Outcomes by <i>EGFR</i> Exon 19 Deletion VariantsKazumi Nishino, Jin-Yuan Shih, Kazuhiko Nakagawa, et al.
Critical Reviews in Oncology/Hematology|May 17, 2019
Multidisciplinary expert opinion on the treatment consensus for patients with EGFR mutated NSCLC with brain metastasesSantiago Ponce, Jordi Bruna, Oscar Juan, et al.
JAMA Neurology|March 15, 2021
Encephalitis Induced by Immune Checkpoint Inhibitors: A Systematic ReviewRoser Velasco, Macarena Villagrán, Maria Jové, et al.
International Journal of Molecular Sciences|February 13, 2026
Urinary Chemokines in the Diagnosis and Monitoring of Immune Checkpoint Inhibitor-Associated NephritisFrancisco Gomez-Preciado, Laura Martinez-Valenzuela, Paula Anton-Pampols, et al.
BMC Pulmonary Medicine|March 3, 2021
Prognostic value of the preoperative lymphocyte-to-monocyte ratio for survival after lung cancer surgeryRicard Ramos, Ivan Macía, Arturo Navarro-Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2014
A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinomaErnest Nadal, Jinjie Zhong, Jules Lin, et al.
Molecular Oncology|November 9, 2023
Transcriptional analysis of landmark molecular pathways in lung adenocarcinoma results in a clinically relevant classification with potential therapeutic implicationsSara Hijazo-Pechero, Ania Alay, David Cordero, et al.
Scientific Reports|July 24, 2015
A Novel Serum 4-microRNA Signature for Lung Cancer DetectionErnest Nadal, Anna Truini, Asuka Nakata, et al.
Pageof 17